www.ncbi.nlm.nih.gov/pubmed/25560712
Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, Turpie AG, Bormanis J, Weitz J, Chamberlain M, Bowie D, Barnes D, Hirsh J. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000 Mar; 83(3):416-20. PubMed PMID: 10744147.
Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, Perrier A.Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006 Feb 7; 144(3):165-71. PubMed PMID: 16461960.
Singh B, Mommer SK, Erwin PJ, Mascarenhas SS, Parsaik AK. Pulmonary embolismrule-out criteria (PERC) in pulmonary embolism–revisited: a systematic review and meta-analysis. Emerg Med J. 2013 Sep; 30(9):701-6. doi:10.1136/emermed-2012-201730. Epub 2012 Oct 4. Review. PubMed PMID: 23038695.
www.anticoagulationtoolkit.org
Roy PM, Moumneh T, Penaloza A, Sanchez O. Outpatient management of pulmonaryembolism. Thromb Res. 2017 Jul; 155:92-100. doi: 10.1016/j.thromres.2017.05.001. Epub 2017 May 4. Review. PubMed PMID: 28525830.
Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ,Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ,Zierler BK; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011 Apr 26; 123(16):1788-830. Doi: 10.1161/CIR.0b013e318214914f. Epub 2011 Mar 21. Erratum in: Circulation. 2012 Aug 14; 126(7):e104. Circulation. 2012 Mar 20; 125(11):e495. PubMed PMID: 21422387.
Piran S, Le Gal G, Wells PS, Gandara E, Righini M, Rodger MA, Carrier M.Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis. Thromb Res. 2013 Nov; 132(5):515-9. doi:10.1016/j.thromres.2013.08.012. Epub 2013 Aug 28. Review. PubMed PMID: 24035045.
Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood. 2012 Oct 11; 120(15):2954-62. doi:10.1182/blood-2012-06-415943. Epub 2012 Aug 28. Review. PubMed PMID: 22932800.
Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010 Aug 9; 170(15):1383-9. doi: 10.1001/archinternmed.2010.199. PubMed PMID: 20696966.
Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, FineMJ. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005 Oct 15; 172(8):1041-6. Epub 2005 Jul 14. PubMed PMID: 16020800; PubMed Central PMCID: PMC2718410.
Jiménez D, Yusen RD. Prognostic models for selecting patients with acutePulmonary embolism for initial outpatient therapy. Curr Opin Pulm Med. 2008Sep; 14(5):414-21. Doi: 10.1097/MCP.0b013e3283043e44. Review. PubMed PMID:18664971.
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N,Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014 Nov 14; 35(43):3033-69, 3069a-3069k. doi: 10.1093/eurheartj/ehu283. Epub 2014 Aug 29. Erratum in: Eur Heart J. 2015 Oct 14; 36(39):2666. Eur Heart J. 2015 Oct 14; 36(39):2642. PubMed PMID: 25173341.
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M,King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016 Feb; 149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7. PubMed PMID: 26867832.
Goldhaber SZ, Piazza G. Optimal duration of anticoagulation after venousthromboembolism. Circulation. 2011 Feb 15; 123(6):664-7. doi:10.1161/CIRCULATIONAHA.110.970822. PubMed PMID: 21321182
Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ,Veenstra DL, Crowther M, Guyatt GH. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e152S-e184S. doi: 10.1378/chest.11-2295. Review. PubMed PMID: 22315259.
Piazza G. Venous thromboembolism and cancer. Circulation. 2013 Dec17; 128(24):2614-8. doi: 10.1161/CIRCULATIONAHA.113.002702. PubMed PMID: 24344060.
Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V,Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A; PROLONG Investigators. D-dimer testing to determine the duration of anticoagulationtherapy. N Engl J Med. 2006 Oct 26; 355(17):1780-9. Erratum in: N Engl J Med. 2006 Dec 28; 355(26):2797. PubMed PMID: 17065639.
Kearon C, Spencer FA, O’Keeffe D, Parpia S, Schulman S, Baglin T, Stevens SM, Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Solymoss S,Crowther M, Perrier A, White R, Vickars L, Ramsay T, Betancourt MT, Kovacs MJ. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ. 2008 Aug 26;179(5):417-26. doi: 10.1503/cmaj.080493. PubMed PMID: 18725614.
Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S, Prisco D, Poli D, Tripodi A, Palareti G; Prolong Investigators. Sex, age and normalpost-anticoagulation D-dimer as risk factors for recurrence after idiopathicvenous thromboembolism in the Prolong study extension. J Thromb Haemost. 2010Sep;8(9):1933-42. doi: 10.1111/j.1538-7836.2010.03955.x. PubMed PMID: 20553388.
Eichinger S, Heinze G, Jandeck LM, Kyrle PA. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation. 2010 Apr 13;121(14):1630-6. doi:10.1161/CIRCULATIONAHA.109.925214. Epub 2010 Mar 29. PubMed PMID: 20351233.Kaatz S, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Moll S, Connors JM,Ginsberg JS, Spadafora L, Julian JA; D-dimer Optimal Duration Study Investigators. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med. 2015 Jan 6; 162(1):27-34. doi: 10.7326/M14-1275. PubMed PMID: 25560712.
Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR,Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ; PREVENT Investigators. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003 Apr 10; 348(15):1425-34. Epub 2003 Feb 24. PubMed PMID: 12601075.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A,Raskob GE, Weitz JI; AMPLIFY-EXT Investigators. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013 Feb 21; 368(8):699-708. doi: 10.1056/NEJMoa1207541. Epub 2012 Dec 8. PubMed PMID: 23216615.
EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR,Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010 Dec 23; 363(26):2499-510. doi: 10.1056/NEJMoa1007903. Epub 2010 Dec 3. PubMed PMID: 21128814.
Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, KvammeAM, Friedman J, Mismetti P, Goldhaber SZ; RE-MEDY Trial Investigators; RE-SONATE Trial Investigators. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med. 2013 Feb 21; 368(8):709-18. doi: 10.1056/NEJMoa1113697. PubMed PMID: 23425163.
Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. N Engl J Med. 2017 Mar 30; 376(13):1211-1222. doi: 10.1056/NEJMoa1700518. Epub 2017 Mar 18. PubMed PMID: 28316279.
Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M,Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P; WARFASAInvestigators. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med. 2012 May 24; 366(21):1959-67. doi: 10.1056/NEJMoa1114238. Erratum in: N Engl J Med. 2012 Oct 18; 367(16):1573. PubMed PMID: 22621626.
Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H,Hague W, Xavier D, Diaz R, Kirby A, Simes J; ASPIRE Investigators. Low-doseaspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012 Nov 22; 367(21):1979-87. doi: 10.1056/NEJMoa1210384. Epub 2012 Nov 4. PubMed PMID: 23121403.
Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, Prandoni P, Brighton TA; INSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism). Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation. 2014 Sep 23; 130(13):1062-71. doi: 10.1161/CIRCULATIONAHA.114.008828. Epub 2014 Aug 25. PubMed PMID: 25156992.
Piazza G. Thrombophilia testing, recurrent thrombosis, and women’s health.Circulation. 2014 Jul 15; 130(3):283-7. doi:10.1161/CIRCULATIONAHA.113.007664. PubMed PMID: 25024124.
Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR.Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 2005 May 18; 293(19):2352-61. PubMed PMID: 15900005.
Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, vander Meer J. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation. 2010 Apr 20; 121(15):1706-12. doi: 10.1161/CIRCULATIONAHA.109.906347. Epub 2010 Apr 5. PubMed PMID: 20368522.
Raja AS, Greenberg JO, Qaseem A, Denberg TD, Fitterman N, Schuur JD; Clinical Guidelines Committee of the American College of Physicians. Evaluation ofPatients with Suspected Acute Pulmonary Embolism: Best Practice Advice from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2015 Nov 3; 163(9):701-11. doi: 10.7326/M14-1772. Epub 2015 Sep 29. PubMed PMID: 26414967.
Singh B, Mommer SK, Erwin PJ, Mascarenhas SS, Parsaik AK. Pulmonary embolismrule-out criteria (PERC) in pulmonary embolism–revisited: a systematic review and meta-analysis. Emerg Med J. 2013 Sep; 30(9):701-6. doi:10.1136/emermed-2012-201730. Epub 2012 Oct 4. Review. PubMed PMID: 23038695.
Righini M, Van ES J, Den Exter PL, Roy PM, Verschuren F, Ghuysen A, Rutschmann OT, Sanchez O, Jaffrelot M, Trinh-Duc A, Le Gall C, Moustafa F, Principe A, Van Houten AA, Ten Wolde M, Douma RA, Hazelaar G, Erkens PM, Van Kralingen KW, Grootenboers MJ, Durian MF, Cheung YW, Meyer G, Bounameaux H, Huisman MV, Kamphuisen PW, Le Gal G. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014 Mar 19; 311(11):1117-24. doi: 10.1001/jama.2014.2135. Erratum in: JAMA. 2014 Apr 23-30; 311(16):1694. PubMed PMID: 24643601.